Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer
1 other identifier
interventional
57
1 country
1
Brief Summary
The goal of this interdisciplinary pilot study is to evaluate the feasibility, acceptability and preliminary efficacy of a guided imagery intervention to reduce radiotherapy-related symptoms of anxiety and depression in patients with head and neck cancers relative to treatment as usual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable head-and-neck-cancer
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2018
CompletedFirst Posted
Study publicly available on registry
September 7, 2018
CompletedStudy Start
First participant enrolled
October 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2021
CompletedResults Posted
Study results publicly available
August 5, 2024
CompletedMarch 13, 2025
March 1, 2025
2.1 years
August 31, 2018
December 9, 2021
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The Desire for Patients to Want to Use Guided Imagery While Undergoing Radiotherapy: [Feasibility]
Feasibility of intervention use will be assessed through rates of study completion.
From baseline to one month post-radiotherapy.
The Desire for Patients to Want to Use Guided Imagery While Undergoing Radiotherapy: [Feasibility]
Feasibility of intervention use will be assessed through rates of GI session attendance.
From baseline to week one of radiotherapy.
The Desire for Patients to Want to Use Guided Imagery While Undergoing Radiotherapy: [Feasibility]
Feasibility of intervention use will be assessed through self-reported use of the GI intervention measured through timeline follow-back.
From baseline to one month post-radiotherapy, up to 12 weeks.
The Amount of Patients Who Find Using Guided Imagery Beneficial as a Form of Treatment While Undergoing Radiotherapy: [Acceptability]
Acceptability of the intervention will be assessed through qualitative interviews with intervention participants. The interviews will assess participant experience in the intervention including thoughts about the intervention content and structure of the intervention. Qualitative data regarding acceptability of the intervention will be gathered through one-on-one, standardized open-ended interviews.
From baseline to one month post-radiotherapy.
Secondary Outcomes (3)
Change From Baseline in Hospital Anxiety and Depression Scales (HADS) Score
Baseline and completion of radiotherapy at 7 weeks
Change From Baseline in Memorial Symptom Assessment Scale Short Form (MSAS-SF) Score
Baseline and end of radiotherapy at 7 weeks.
The Effect Guided Imagery Has on Distress While Undergoing Radiotherapy: [Impact]
From baseline to completion of radiotherapy at 7 weeks.
Study Arms (2)
Guided Imagery
EXPERIMENTALThe GI intervention will include direct, written, and audio delivery of one of three GI vignettes (depiction).The patient will be able to choose one of the three vignettes.
Treatment as Usual
ACTIVE COMPARATORThe control, or treatment as usual condition, will include an orientation to radiotherapy from the clinic nurse coordinator.
Interventions
GI is a relaxation technique involving the visualization of images and is considered an adjuvant cancer therapy.The GI intervention will include two hour-long meetings between the participant and a trained interventionist. The sessions will include direct, written, and audio delivery of one of three GI vignettes. The patient will be able to choose one of the three vignettes. The approximately twelve minute long vignettes included in the study will be: Taking a Walk, Healthy Cell Alliance for Treatment, and Daily Intention (32). Patients will also be given access to psychosocial support resources (i.e., clinical psychologists and social workers) at University of Colorado Cancer Center.
This will include a tour of the treatment room and education about RT. Patients will also receive educational materials about RT including the process of RT and CT simulation, treatment side effects, pain management, and swallowing exercises. Participants in this condition will also have access to psychosocial support resources (i.e., clinical psychologists and social workers) at University of Colorado Cancer Center.
Eligibility Criteria
You may qualify if:
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Be aged 18 - 100.
- Ability to read and communicate in English.
- A confirmed malignancy of the head and neck region (including metastases from other primary tumors and cancers of unknown primary.
- Initiation of RT at the University of Colorado Cancer Center.
- Psychiatric and cognitive stability as assessed by chart review (i.e., no documented dementia diagnosis or unmanaged psychiatric symptoms) and study personnel (i.e., ability to attend to meeting with study personnel).
- Ability to meet remotely via internet connection or over the phone.
You may not qualify if:
- Those who are determined, by mental health professionals, to be psychiatrically unstable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Related Publications (1)
Kolva E, Karam SD, Carr AL, Roberts S, Torkko K, Lanning R, Cox-Martin E. Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer. Pilot Feasibility Stud. 2022 Sep 5;8(1):199. doi: 10.1186/s40814-022-01134-9.
PMID: 36064748DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jamie Studts
- Organization
- University of Colorado Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Elissa Kolva
University of Colorado, Denver
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to study design, it is not possible to blind either participants or investigators to study condition. However, the biostatistician will be blinded to participant group to minimize bias in analyzing the data.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2018
First Posted
September 7, 2018
Study Start
October 12, 2018
Primary Completion
November 9, 2020
Study Completion
January 8, 2021
Last Updated
March 13, 2025
Results First Posted
August 5, 2024
Record last verified: 2025-03